Midazolam oral - Primex Pharmaceuticals

Drug Profile

Midazolam oral - Primex Pharmaceuticals

Alternative Names: ADV 6209; Ozaline

Latest Information Update: 07 Mar 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Advicenne
  • Developer Primex Pharmaceuticals
  • Class Benzodiazepines; Hypnosedatives; Sleep disorder therapies; Small molecules
  • Mechanism of Action GABA A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preregistration Anaesthesia; Sedation

Most Recent Events

  • 07 Mar 2017 Chemical structure information added
  • 05 Oct 2016 Preregistration for Anaesthesia (In children, In infants, In adolescents) in France, Finland, United Kingdom, Netherlands, Italy (PO)
  • 05 Oct 2016 Preregistration for Sedation (In adolescents, In children, In infants) in France, Finland, United Kingdom, Netherlands, Italy (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top